Call us +91 -7376325889/ 7376335889
Mail
Support
Partners
Careers
Knowledge Center
Downloads
Margin Calculator
Equity
F&O
MF
Online Trading
Open an Account
Back Office
Apply IPO
ABOUT US
SERVICES
MARKETS
Equity
Derivatives
Mutual Fund
IPO
PORTFOLIO
OUR RECOMMENDATIONS
CONTACT US
CALCULATORS
MENU
×
HOME
SERVICES
MARKETS
PORTFOLIO
OUR RECOMMENDATIONS
ABOUT US
SERVICES
CONTACT US
CALCULATORS
Online Trading
Open an Account
Back Office
Apply IPO
Equity Analysis
Company Profile
Price
Volume
Analysis
Company Profile
News Analysis
Corporate Action
Other Markets
Detailed Quotes
Detailed Quotes
Company Snapshot
Company Background
Board of Directors
Profit & Loss
Balance Sheet
Quarterly Results
Key Financial Ratios
Share Holding Pattern
Directors Report
Score Board
MF Holdings
Name Change
Company News
Peer Comparison
Monthly High / Low
Price Chart
Consolidated Quarters
FII Holding
Simple & CAGR Growth
Deliverable Volumes
Profit & Loss
Bliss GVS Pharma Ltd
Industry : Pharmaceuticals - Indian - Formulations
BSE Code
ISIN Demat
Book Value(
)
506197
INE416D01022
97.2888746
NSE Symbol
P/E(TTM)
Mar.Cap(
Cr.)
BLISSGVS
16.8
1358.4
EPS(TTM)
Face Value(
)
Div & Yield %:
7.68
1
0.39
Particulars(INCOME)
Mar 2024
(
Cr)
Mar 2023
(
Cr)
Mar 2022
(
Cr)
Mar 2021
(
Cr)
Mar 2020
(
Cr)
Mar 2019
(
Cr)
Sales Turnover
605.46
598.34
636.36
465.51
441.95
426.59
Excise Duty
0.00
0.00
0.00
0.00
0.00
0.00
Net Sales
605.46
598.34
636.36
465.51
441.95
426.59
Other Income
33.50
50.77
35.37
17.68
37.00
35.81
Stock Adjustments
6.36
-21.24
8.90
8.85
-2.37
3.68
Total Income
645.32
627.87
680.63
492.04
476.58
466.08
EXPENDITURE :
Raw Materials
305.83
293.66
352.84
262.15
234.36
228.83
Power & Fuel Cost
8.81
5.80
7.09
6.99
4.70
3.57
Employee Cost
82.59
72.54
65.06
58.61
44.02
33.85
Other Manufacturing Expenses
17.25
11.57
11.54
7.49
6.23
6.49
Selling & Administrative Expenses
66.73
66.90
67.07
36.90
36.23
43.93
Miscellaneous Expenses
64.52
36.48
32.45
10.76
13.88
20.51
Less : Pre-operative Expenses Capitalised
0.00
0.00
0.00
0.00
0.00
0.00
Total Expenditure
545.74
486.95
536.05
382.90
339.42
337.17
Operating Profit
99.59
140.93
144.57
109.14
137.16
128.91
Interest
5.81
10.06
4.32
4.19
6.62
3.15
Gross Profit
93.78
130.87
140.25
104.95
130.54
125.76
Depreciation
23.52
15.17
13.85
13.76
8.83
5.75
Profit Before Tax
70.26
115.70
126.40
91.19
121.71
120.01
Tax
26.34
34.42
31.92
21.52
31.81
45.44
Fringe Benefit tax
0.00
0.00
0.00
0.00
0.00
0.00
Deferred Tax
-6.72
-4.21
1.81
2.16
-2.44
0.14
Reported Net Profit
50.64
85.48
92.66
67.50
92.33
74.43
Extraordinary Items
-25.47
0.26
2.09
-0.02
0.53
-1.47
Adjusted Net Profit
76.11
85.22
90.57
67.52
91.80
75.90
Adjustment below Net Profit
-0.15
-0.67
0.30
0.52
-0.26
-0.17
P & L Balance brought forward
846.18
765.33
676.22
613.36
533.69
471.84
Statutory Appropriations
0.00
0.00
0.00
0.00
0.00
0.00
Appropriations
4.10
3.97
3.86
5.16
12.41
12.41
P & L Balance carried down
892.57
846.18
765.33
676.22
613.36
533.69
Dividend
0.00
0.00
0.00
0.00
0.00
0.00
Preference Dividend
0.00
0.00
0.00
0.00
0.00
0.00
Equity Dividend %
50.00
50.00
50.00
50.00
50.00
100.00
Dividend Per Share(Rs)
0.50
0.50
0.50
0.50
0.50
1.00
Earnings Per Share-Unit Curr
4.84
8.21
8.94
6.54
8.95
7.22
Earnings Per Share(Adj)-Unit Curr
4.84
8.21
8.94
6.54
8.95
7.22
Book Value-Unit Curr
94.41
89.96
82.12
73.26
66.21
58.49
Book Value(Adj)-Unit Curr
94.41
89.96
82.12
73.26
66.21
58.49